Abstract: Disclosed herein are reconfigurable antennas based on moiré patterns with new actuation mechanisms to reduce their energy expenditure.

Abstract: An electromagnetic (EM)-based diagnostics and monitoring system and method for the non-Invasive diagnosis and monitoring of in-vivo and ex-vivo Skin Anomalies Using Lesion-Optimized Sensor System Design and Topology is disclosed herein.

Abstract: A multi-power-mode ultra-low-power address detector for Radio Frequency (RF) wakeup receivers is provided herein. The address detector is implemented when combined charging and wake-up of a device is required. The method includes a set of components to process a complex address waveform. This address includes a preamble composed of a pulse with a specific width, followed by a digital Pulse Width Modulation (PWM) modulated bit pattern.

Abstract: The Combination of Topical Medications for the Treatment of Skin Diseases and Methods of Use is disclosed.

Abstract: The device measures glucose concentration in blood without any extraction of blood. The device is a non-invasive method for measuring glucose Radio Frequency and Antenna Circuits and Systems. The device is a wearable device that can non-invasively measure blood glucose levels in an instantaneous manner and continuous manner.

Abstract: Composition and use of macro-minerals to lower postprandial glycemic response and reduce body weight are disclosed herein.

Abstract: Provided herein are systems, methods and apparatuses for an Antenna Design for Biomarker Monitoring.

Abstract: Provided herein are systems, methods and apparatuses for surgical forceps for an easier and safer retrieval of foreign bodies in passages for better quality of care for patients.

Abstract: The present invention relates to mutated factor (FX) polypeptides and uses thereof for the treatment of haemophilia. In particular, the present invention relates to a mutated factor X (FX) polypeptide which comprises a heavy chain wherein at least one amino acid residue at position 401 or 408 is mutated.

Abstract: The present invention relates to methods and pharmaceutical compositions for the treatment of acute myeloid leukemia. In particular, the present invention relates to a method for treating NPM-1-driven acute myeloid leukemia (AML) in a subject in need thereof comprising administering the subject with a therapeutically effective amount of at least one arsenic compound and with a therapeutically effective amount of at least one retinoid.

Abstract: Provided herein are systems, methods and apparatuses for a thickness measurement device based on a capacitive array.

Abstract: Provided herein is a device for measuring puff topography generated by a human user of a smoking device and methods for using the same. The device may be used for research on puffing behavior of tobacco product users in both clinical and non-clinical settings.

Abstract: A method for a determining of risk for development of cardiovascular disease by measuring levels of the at least gene of interest is disclosed. The method may identify subjects with moderate albuminuria and diagnosis or predict cardiovascular disease several years before either of these outcomes is detectable by present methodologies.

Abstract: A system and method for Automated Detection and Measurement of Corneal Haze and the Demarcation Line is disclosed. Data extraction module performs visual data and statistics generation to detect corneal haze and calculate corneal attributes in images.

Abstract: A context aware mobile personalization system is disclosed for a software development environment with plug-in capabilities for providing personalized phone capabilities based on the automated detection of user context.

Abstract: The Multi-Device Continuum and Seamless Sensing Platform for Context Aware Analytics provide a platform for continuous sensing across multiple devices towards a unified target. The Multi-Device Continuum and Seamless Sensing Platform provides a platform for extracting, loading, integrating, and tracking related data across multiple smart devices capable of integrating with internal and external sensors, such as wearable devices. The Multi-Device Continuum and Seamless Sensing Platform develop context aware solutions, which are targeted at automated recognition of context extracted from users' devices, as people are often always interacting with a digital device such as phone, tablet, or desktop.

Abstract: A method of transmitting a multi-carrier source signal, including symbols constituted by reserved carriers and data carriers. The method includes generating an additional signal that reduces peak-to-average power ratio of the signal to be transmitted. For each symbol, the method obtains M time samples representing the symbols and/or at least one iteration of: detecting P time samples from among P time samples representing the symbol, the P samples being the P samples of the highest amplitude among the M samples, or the P samples presenting a power value above a threshold; in the frequency domain, activating a reserved carrier, by addition of a pre-determined power to the reserved carrier; and for each activated reserved carrier: obtaining M time samples representing the activated reserved carrier, and applying a phase shift, taking account of the P detected samples, to the M time samples representing the activated reserved carrier.

Abstract: The SACOS apparatus solves counterfeiting issues instantaneously and develops new security features in order to improve the role that international regulatory commissions, governments, and central banks play to effectively fight counterfeiting.

Abstract: The present invention relates to methods, pharmaceutical compositions and kits for use in the treatment of Adult T-cell leukemia/lymphoma. More particularly, the present invention relates to a combination of an interferon, an arsenic compound and a reverse transcriptase inhibitor for the treatment of Adult T-cell leukemia/lymphoma.